Atossa Genetics Inc news

   Watch this stock
Showing stories 1 - 10 of about 78   

Articles published

ATOS 0.258 -0.002 (-0.77%)
price chart
Atossa Genetics Inc (NASDAQ:ATOS) Explodes Up The Charts
Shares of Atossa Genetics Inc (NASDAQ:ATOS) have exploded up the charts recently on news of insider buying and optimism for upcoming clinical trial updates.
Insiders Increasing Positions in: Atossa Genetics, Inc. (NASDAQ:ATOS)
According to the latest SEC filings, insiders at Atossa Genetics, Inc. (NASDAQ:ATOS) have increased their position in the stock by 10.49% over the past 6 months.
Ambitious Atossa Genetics Going After Two Breast Cancer Blockbusters
That technology is now licensed to Atossa Genetics (ATOS), a small biotech about 1/7900th of Abbvie's size. Atossa has licensed a gel reformulation of AstraZeneca's (NYSE:AZN) Nolvadex, better known as generic tamoxifen. Tamoxifen is the most popular ...
Stock Earnings Analysis: Atossa Genetics Inc (NASDAQ:ATOS)
Atossa Genetics Inc (NASDAQ:ATOS) on Mar 30, 2016 declared 2015 financial results and provided an update on recent company developments.
Thursday's Penny Stocks To Watch: Atossa Genetics (ATOS), International ...  SmallCap Network
Atossa Genetics | $ATOS Stock | Is Something Brewing At Atossa ?
A little-known biotech company which specializes in women's health, (specifically, breast cancer prevention) has been showing up on small-cap and penny stock traders radar for the last few days to a few weeks.
Atossa Genetics: Spotty Track Record And Short On Cash (ATOS)
Atossa Genetics (NASDAQ:ATOS) went up over 40% in early trading when it announced Henry Schein will offer Atossa Genetics' FullCYTE Breast Aspirator on Feb 26th, 2015. Traders and investors have been repetitively trapped by this type of trivial news ...
Atossa Genetics Inc. Hires Pieter van der Poel as Vice President of European ...
SEATTLE, WA--(Marketwired - Dec 16, 2014) - Atossa Genetics Inc. ( NASDAQ : ATOS) today announced that it has hired Pieter van der Poel as Vice President of European Commercial Operations effective December 15, 2014.
Related articles »  
HC Stocks Reports: Atossa Genetics Inc (NASDAQ:ATOS), NovaBay Pharmaceuticals ...
Shares of Atossa Genetics Inc (NASDAQ:ATOS) ended Friday session in red amid volatile trading. The shares closed down -0.007 points or -2.74% at $0.263 with 111,851.00 shares getting traded.
Atossa Genetics, Inc. (NASDAQ:ATOS) Has Huge Plans to Reverse the Downtrend
Atossa Genetics, Inc. (NASDAQ:ATOS) stock broke the trading range on Monday as the company' recent press release announcing a new license agreement caught the attention of traders.
Atossa Genetics secures global license to Afimoxifene Gel (ATOS)  Seeking Alpha
FY2016 Earnings Forecast for Atossa Genetics Inc Issued By Zacks Investment ...
Atossa Genetics logo Atossa Genetics Inc (NASDAQ:ATOS) - Equities research analysts at Zacks Investment Research increased their FY2016 earnings per share (EPS) estimates for shares of Atossa Genetics in a research note issued to investors on ...